Connect with us

Hi, what are you looking for?

Life

A herpes-based drug was successfully used to treat skin cancer

This could end up paving the way for a new generation of treatments for cancer. The findings of this trial marked the first positive phase of 3 trial results for cancer Virotherapy.

If the drug, T-VEC, could be more widely available for cancer patients by next year. T-Vec is a modified derivative of the herpes virus that causes cold sores. The drug is injected into the tumor. After it has been injected, GM-CSF (granulocyte-macrophage colony-stimulating factor) is produced, and this stimulates an immune response which fights the cancer.

The trial was conducted by scientists at the Institute for Cancer Research in London. One in 10 of the 26 percent of patients who responded to the herpes virus treatment saw that their tumors vanished completely. Another 16 percent of patients saw their tumors reduce in size by more than 50 percent.

The phase III trial was led by professor Kevin Harrington, and it involved 436 patients. Some were given the treatment and other patients were given a control immunotherapy. Harrington said that it is not an exaggeration to say that this is a first-in class agent, and a brand new type of cancer treatment.

Written By

You may also like:

Social Media

Wanna buy some ignorance? You’re in luck.

Business

United Airlines CEO Scott Kirby said the carrier was reviewing recent incidents and would redouble safety initiatives as needed - Copyright AFP Logan CyrusUnited...

World

US President Joe Biden speaks during a reception honoring Women's History Month at the White House - Copyright AFP Brendan SMIALOWSKIDanny KEMPUS President Joe...

Business

A Milei marks 100 days in office, thousands protest his austerity measures - Copyright AFP Luis ROBAYOLeila MACORArgentina’s President Javier Milei has slashed public...